Efficacy and safety of filgotinib in patients with active radiographic and nonradiographic axial spondyloarthritis: results from OLINGUITO, a phase 3 trial consisting of 2 randomised, placebo-controlled, double-blind, parallel-group studies.
- DOI
- 10.1016/j.ard.2026.06.024
- Published
- 2026 Aug 12
- Container
- Annals of the rheumatic diseases
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ard.2026.06.024,
title = {Efficacy and safety of filgotinib in patients with active radiographic and nonradiographic axial spondyloarthritis: results from OLINGUITO, a phase 3 trial consisting of 2 randomised, placebo-controlled, double-blind, parallel-group studies.},
author = {Baraliakos X and Maksymowych WP and Navarro-Compán V and van der Heijde D and Landewé R and Machado PM and Zubrzycka-Sienkiewicz A and Kiltz U and Závada J and Lowe J and Gheyle L and Mangili A and Mutter R and Le Brun FO and Muller K and Van den Bosch F},
year = {2026},
journal = {Annals of the rheumatic diseases},
doi = {10.1016/j.ard.2026.06.024},
url = {https://doi.org/10.1016/j.ard.2026.06.024}
}RIS
TY - JOUR TI - Efficacy and safety of filgotinib in patients with active radiographic and nonradiographic axial spondyloarthritis: results from OLINGUITO, a phase 3 trial consisting of 2 randomised, placebo-controlled, double-blind, parallel-group studies. AU - Baraliakos X AU - Maksymowych WP AU - Navarro-Compán V AU - van der Heijde D AU - Landewé R AU - Machado PM AU - Zubrzycka-Sienkiewicz A AU - Kiltz U AU - Závada J AU - Lowe J AU - Gheyle L AU - Mangili A AU - Mutter R AU - Le Brun FO AU - Muller K AU - Van den Bosch F PY - 2026 JO - Annals of the rheumatic diseases DO - 10.1016/j.ard.2026.06.024 UR - https://doi.org/10.1016/j.ard.2026.06.024 ER -
APA
X, B., WP, M., V, N., D, V. D. H., R, L., PM, M., A, Z., U, K., J, Z., J, L., L, G., A, M., R, M., FO, L. B., K, M., & F, V. D. B. (2026). Efficacy and safety of filgotinib in patients with active radiographic and nonradiographic axial spondyloarthritis: results from OLINGUITO, a phase 3 trial consisting of 2 randomised, placebo-controlled, double-blind, parallel-group studies.. Annals of the rheumatic diseases. https://doi.org/10.1016/j.ard.2026.06.024
Source records
- pubmed · retrieved 2026-09-25T16:38:01.722Z